metformin has been researched along with Atrophy in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our findings revealed that metformin could induce endometrial atrophy in 21 out of 22 patients (95." | 5.19 | Antiproliferative effect of metformin on the endometrium--a clinical trial. ( Bidadi, S; Foroughi, M; Ghojazadeh, M; Melli, MS; Tabrizi, AD, 2014) |
| "Metformin (200mg/kg) was given at the time of reperfusion daily until sacrifice." | 1.40 | Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion. ( Liu, Y; Tang, G; Wang, Y; Yang, GY; Zhang, Z, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antal, B | 1 |
| McMahon, LP | 1 |
| Sultan, SF | 1 |
| Lithen, A | 1 |
| Wexler, DJ | 1 |
| Dickerson, B | 1 |
| Ratai, EM | 1 |
| Mujica-Parodi, LR | 1 |
| Nabizadeh, F | 1 |
| Kankam, SB | 1 |
| Balabandian, M | 1 |
| Hashemi, SM | 1 |
| Sharifkazemi, H | 1 |
| Rostami, MR | 1 |
| Liu, Y | 1 |
| Tang, G | 1 |
| Zhang, Z | 1 |
| Wang, Y | 1 |
| Yang, GY | 1 |
| Tabrizi, AD | 1 |
| Melli, MS | 1 |
| Foroughi, M | 1 |
| Ghojazadeh, M | 1 |
| Bidadi, S | 1 |
| Liberati-Čizmek, AM | 1 |
| Kruljac, I | 1 |
| Bakula, M | 1 |
1 review available for metformin and Atrophy
| Article | Year |
|---|---|
Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses.
Topics: Aged; Aged, 80 and over; Aging; Atrophy; Biological Specimen Banks; Cognitive Dysfunction; Cross-Sec | 2022 |
1 trial available for metformin and Atrophy
| Article | Year |
|---|---|
Antiproliferative effect of metformin on the endometrium--a clinical trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Atrophy; Carcinoma, Endometrioid; Endometrial Hyperplasia; E | 2014 |
3 other studies available for metformin and Atrophy
| Article | Year |
|---|---|
Metformin use and brain atrophy in nondemented elderly individuals with diabetes.
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Cognitive Dysfunction; Diabetes Mellitus; Hippocampus; Huma | 2022 |
Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion.
Topics: Animals; Atrophy; Brain; Cyclic AMP-Dependent Protein Kinases; Doublecortin Protein; Hypoglycemic Ag | 2014 |
A 65-year-old female with poorly controlled type 2 diabetes mellitus.
Topics: Aged; Atrophy; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; | 2015 |